Positions

Selected Publications

Academic Article

Year Title Altmetric
2023 Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myelomaBritish Journal of Haematology.  200:824-827. 2023
2023 Camera-Based Short Physical Performance Battery and Timed Up and Go Assessment for Older Adults with CancerIEEE Transactions on Biomedical Engineering2023
2023 Patient-reported geriatric assessment-based frailty index among older adults with gastrointestinal malignanciesJournal of the American Geriatrics Society.  71:136-144. 2023
2022 Adaptation of Remote Symptom Monitoring Using Electronic Patient-Reported Outcomes for Implementation in Real-World SettingsJco Oncology Practice.  18:E1943-E1952. 2022
2022 Body composition from single versus multi-slice abdominal computed tomography: Concordance and associations with colorectal cancer survivalJournal of Cachexia, Sarcopenia and Muscle.  13:2974-2984. 2022
2022 Pain among older adults with gastrointestinal malignancies- results from the cancer and aging resilience evaluation (CARE) RegistrySupportive Care in Cancer.  30:9793-9801. 2022
2022 Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapyBlood Cancer Journal.  12. 2022
2022 Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results from the Cancer and Aging Resilience Evaluation RegistryJco Oncology Practice.  18:E1796-E1806. 2022
2022 Disparities in clinical trial participation among older adults with multiple myeloma in the United StatesJournal of Geriatric Oncology.  13:1241-1243. 2022
2022 Predicting Postallogeneic Hematopoietic Cell Transplant Glucose Intolerance: The Role of CT-based Body CompositionCancer Epidemiology, Biomarkers and Prevention.  31:2002-2003. 2022
2022 Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple MyelomaJournal of Clinical Oncology.  40:2901-2912. 2022
2022 Geriatric Assessment Predictors of 1-Year Mortality in Older Adults With GI Malignancies: A Survival Tree AnalysisJCO Clinical Cancer Informatics.  6:e2200065. 2022
2022 Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapyAmerican Journal of Hematology.  97:1170-1177. 2022
2022 Evaluating real-world treatment patterns and outcomes of mantle cell lymphomaBlood Advances.  6:4122-4131. 2022
2022 Racial disparities in frailty and geriatric assessment impairments in older adults with cancer in the Deep South: Results from the CARE RegistryCancer.  128:2313-2319. 2022
2022 Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review 2022
2022 The association of polypharmacy with functional status impairments, frailty, and health-related quality of life in older adults with gastrointestinal malignancy - Results from the Cancer and Aging Resilience Evaluation (CARE) registryJournal of Geriatric Oncology.  13:624-628. 2022
2022 Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myelomaJournal of Geriatric Oncology.  13:486-492. 2022
2022 Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myelomaAmerican Journal of Hematology.  97:E153-E155. 2022
2022 Revisiting the impact of immunoglobulin isotypes in multiple myelomaAnnals of Hematology.  101:825-829. 2022
2022 The Evolution of Geriatric Oncology and Geriatric Assessment over the Past DecadeSeminars in Radiation Oncology.  32:98-108. 2022
2022 Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapiesLeukemia.  36:877-880. 2022
2022 Chemotherapy dosing in older adults with cancer: One size does NOT fit allJournal of Geriatric Oncology2022
2022 Longitudinal changes in patient-reported cognitive complaints among older adults with gastrointestinal malignancies — results from the Cancer and Aging Resilience Evaluation (CARE) RegistryJournal of Cancer Survivorship2022
2022 Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer 2022
2021 Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta-Analysis 2021
2021 Fatigue is independently associated with functional status limitations in older adults with gastrointestinal malignancies—results from the CARE registrySupportive Care in Cancer.  29:6793-6800. 2021
2021 Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myelomaBritish Journal of Haematology.  195:e113-e116. 2021
2021 Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation—A Blood or Marrow Transplant Survivor Study Report 2021
2021 Association between chronologic age and geriatric assessment⇓identified impairments: Findings from the CARE registryJournal of the National Comprehensive Cancer Network : JNCCN.  19:922-927. 2021
2021 Sarcopenia in the Older Adult With CancerJournal of Clinical Oncology.  39:2068-2078. 2021
2021 Reply to SARC-F to screen or diagnose sarcopenia in cancer? A point-blank refusalCancer.  127:2159. 2021
2021 Depression among older adults with gastrointestinal malignanciesJournal of Geriatric Oncology.  12:599-604. 2021
2021 Overall survival based on oncologist density in the United States: A retrospective cohort studyPLoS One.  16. 2021
2021 SARC-F for screening of sarcopenia among older adults with cancerCancer.  127:1469-1475. 2021
2021 Caution with Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma - ReplyJAMA Oncology.  7:635-636. 2021
2021 Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple MyelomaJournal of Clinical Oncology.  39:1119-1128. 2021
2021 New regimens and directions in the management of newly diagnosed multiple myelomaAmerican Journal of Hematology.  96:367-378. 2021
2021 Second primary malignancy among older adults with multiple myeloma receiving first-line lenalidomide-based therapy: A population-based analysisJournal of Geriatric Oncology.  12:256-261. 2021
2021 A Wearable Walking Gait Speed-Sensing Device using Frequency Bifurcations of Multi-Resonator Inductive LinkConference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference.  7272-7275. 2021
2021 Camera-Based Human Gait Speed Monitoring and Tracking for Performance Assessment of Elderly Patients with CancerConference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference.  3522-3525. 2021
2021 Cost-effectiveness of once-weekly selinexor, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma 2021
2020 Association of malnutrition with geriatric assessment impairments and health-related quality of life among older adults with gastrointestinal malignanciesCancer.  126:5147-5155. 2020
2020 Efficacy and safety of frontline regimens for older transplant-ineligible patients with multiple myeloma: A systematic review and meta-analysisJournal of Geriatric Oncology.  11:1285-1292. 2020
2020 Integration of geriatric assessment into routine oncologic care and advances in geriatric oncology: A young International Society of Geriatric Oncology Report of the 2020 American Society of Clinical Oncology (ASCO) annual meetingJournal of Geriatric Oncology.  11:1324-1328. 2020
2020 Trends in the use of therapeutic plasma exchange in multiple myelomaJournal of Clinical Apheresis.  35:307-315. 2020
2020 Simplified frailty assessment tools: are we really capturing frailty or something else?Leukemia.  34:1967-1969. 2020
2020 Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trialsCancer.  126:2791-2801. 2020
2020 Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agentsBlood Advances.  4:2245-2253. 2020
2020 Clinical outcomes of older patients with AML receiving hypomethylating agents: A large population-based study in the United StatesBlood Advances.  4:2192-2201. 2020
2020 Geriatric hematology research at the 2019 American Society of Hematology annual meeting: Young International Society of geriatric oncology perspective paperJournal of Geriatric Oncology.  11:735-739. 2020
2020 Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United StatesBlood Advances.  4:1615-1623. 2020
2020 Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncopePLoS One.  15. 2020
2020 Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents 2020
2020 Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-risk Cytogenetic Factors: A Systematic Review and Meta-analysisJAMA Oncology.  6:1759-1765. 2020
2020 Use of immunosuppressive therapy for management of myelodysplastic syndromes: A systematic review and meta-analysisThe hematology journal : the official journal of the European Haematology Association / EHA.  105:102-111. 2020
2020 Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: A systematic review and meta-analysisThe hematology journal : the official journal of the European Haematology Association / EHA.  105. 2020
2019 Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United StatesCancer.  125:4084-4095. 2019
2019 RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis 2019
2019 Trends of Inpatient Venous Thromboembolism in United States Before and After the Surgeon General's Call to ActionAmerican Journal of Cardiology.  124:960-965. 2019
2019 Factors Associated with Unplanned 30-Day Readmissions after Hematopoietic Cell Transplantation among US HospitalsJAMA Network Open.  2. 2019
2019 Changes to Model Assumptions of the Cost-effectiveness of Durvalumab Therapy for Non-Small Cell Lung CancerJAMA Oncology.  5:1066. 2019
2019 Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis 2019
2019 Effects of center type and socioeconomic factors on early mortality and overall survival of diffuse large B-cell lymphomaFuture Oncology.  15:2113-2124. 2019
2019 Impact of hydroxyurea on survival and risk of thrombosis among older patients with essential thrombocythemiaJournal of the National Comprehensive Cancer Network : JNCCN.  17:211-219. 2019
2019 Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromesAnnals of Hematology.  98:339-350. 2019
2019 Physician experience and risk of rituximab discontinuation in older adults with non-hodgkin's lymphomaJournal of the National Comprehensive Cancer Network : JNCCN.  17:1194-1202. 2019
2018 Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancerPLoS One.  13. 2018
2018 Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphomaCancer.  124:4211-4220. 2018
2018 The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia veraBlood Advances.  2:2681-2690. 2018
2018 Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: Are we using realistic estimates?Blood Cancer Journal.  8. 2018
2017 Early mortality and overall survival of acute myeloid leukemia based on facility typeAmerican Journal of Hematology.  92:764-771. 2017
2017 Penetrating aortic ulcer leading to aortic dissectionJournal of the American Academy of Physician Assistants.  30:23-25. 2017
2017 Second primary malignancy in acute promyelocytic leukemia: A Surveillance, Epidemiology and End Results database studyFuture Oncology.  13:1455-1457. 2017
2017 Leukemic transformation in patients with myeloproliferative neoplasms: A population-based retrospective studyFuture Oncology.  13:1239-1246. 2017
2017 Renal cancer in recipients of kidney transplantRare Tumors.  9:9-13. 2017
2017 Eculizumab in Transplant-Associated Thrombotic Microangiopathy 2017
2017 Cerebral edema among adults with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome: Incidence, characteristics, and outcomesJournal of Diabetes.  9:208-209. 2017
2017 Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic LeukemiaClinical Lymphoma, Myeloma and Leukemia.  17:126-132.e1. 2017
2017 Synchronous or metachronous hairy cell leukemia and chronic lymphocytic leukemia: A case series and literature reviewFrontiers in Oncology.  6. 2017
2017 Addition of rituximab to chemotherapy reduced the rate of surgery for gastric-DLBCL without increasing early mortality 2017
2016 Under-recognition of hemophagocytic syndrome in United States’ rural, non-teaching hospitals 2016
2016 Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemiaWorld Journal of Clinical Oncology.  7:324-330. 2016
2016 Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract 2016
2016 An incidental diagnosis of multiple pacemaker lead fracturesJournal of the American Academy of Physician Assistants.  29:39-41. 2016
2016 Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic SyndromeClinical Lymphoma, Myeloma and Leukemia.  16:230-236. 2016
2016 Acute promyelocytic leukemia during pregnancy: A systematic analysis of outcome 2016
2016 Comparative Survival of Patients with Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal AdenocarcinomaClinical Colorectal Cancer.  15:47-53. 2016
2016 Seasonal variation in acute gouty arthritis: data from Nationwide Inpatient SampleClinical Rheumatology.  35:523-525. 2016
2016 Survival of de novo and secondary acute promyelocytic leukemia: A propensity-matched analysis of the SEER database 2016
2016 A case of right atrial thrombus secondary to hepatocellular carcinoma.Journal of Community Hospital Internal Medicine Perspectives.  6:31443. 2016
2016 Acute megakaryocytic leukemia: What have we learnedBlood Reviews.  30:49-53. 2016
2016 An uncommon cause of acute pulmonary EdemaJournal of the American Academy of Physician Assistants.  29:1-4. 2016
2016 Multiple coronary-cameral fistulas to the left ventricle arising from both coronary arteries.Journal of Community Hospital Internal Medicine Perspectives.  6:31190. 2016
2016 RS3PE revisited: A systematic review and meta-analysis of 331 casesClinical and Experimental Rheumatology.  34:404-415. 2016
2015 A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapySpringerPlus.  4. 2015
2015 Fondaparinux for Management of Heparin-induced Thrombocytopenia after Cardiovascular Intervention: A systematic reviewCardiovascular and Hematological Agents in Medicinal Chemistry.  13:82-86. 2015
2015 Management and outcome of heparin-induced thrombocytopenia in pregnancy: A systematic reviewCardiovascular and Hematological Agents in Medicinal Chemistry.  13:92-97. 2015
2015 New oral anticoagulants for the management of heparin induced thrombocytopenia: A focused literature reviewCardiovascular and Hematological Agents in Medicinal Chemistry.  13:87-91. 2015
2015 Rituximab-induced serum sickness: A systematic reviewSeminars in Arthritis and Rheumatism.  45:334-340. 2015
2015 How center volumes affect early outcomes in acute myeloid leukemiaClinical Lymphoma, Myeloma and Leukemia.  15:646-654. 2015
2015 Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysisAmerican Journal of Hematology.  90:1052-1054. 2015
2015 Incidence of breast cancer among female survivors of Hodgkin lymphoma: A US-population-based trend analysis from 1973 to 2011Blood.  126:1861-1863. 2015
2015 Central Nervous System Complications and Outcomes after Allogeneic Hematopoietic Stem Cell TransplantationClinical Lymphoma, Myeloma and Leukemia.  15:606-611. 2015
2015 Next-generation sequencing and in silico analysis facilitate prolonged response to pazopanib in a patient with metastatic urothelial carcinoma of the renal pelvisJournal of the National Comprehensive Cancer Network : JNCCN.  13:1181-1185. 2015
2015 Pleural epitheliod hemangioendothelioma: What started as a liver fluke and ended up being almost mistaken for malignant mesotheliomaAnnals of Thoracic Medicine.  10:289-291. 2015
2015 Meta-analysis on efficacy and safety of new oral anticoagulants for venous thromboembolism prophylaxis in overweight and obese postarthroplasty patients 2015
2015 Sarcoidosis and antiphospholipid syndrome: A systematic review of casesNorth American Journal of Medical Sciences.  7:379-383. 2015
2015 Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled TrialsAmerican Journal of Cardiovascular Drugs.  15:275-285. 2015
2015 Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]American Journal of Cardiovascular Drugs.  15:287. 2015
2015 Comparison of Coronary Atherosclerotic Plaque Burden and Composition of Culprit Lesions between Cigarette Smokers and Non-Smokers by in Vivo Virtual Histology Intravascular Ultrasound 2015
2015 Racial Differences in the Overall Survival of Hairy Cell Leukemia in the United States: A Population-Based Analysis of the Surveillance, Epidemiology, and End Results DatabaseClinical Lymphoma, Myeloma and Leukemia.  15:484-488. 2015
2015 Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosisLeukemia Research.  39:1342-1346. 2015
2015 Review of Reported Causes of Device Embolization Following Trans-Catheter Aortic Valve ImplantationAmerican Journal of Cardiology.  115:1767-1772. 2015
2015 Ebola paranoia in the age of the internet and social mediaNorth American Journal of Medical Sciences.  7:297. 2015
2015 Early mortality in acute myeloid leukemiaLeukemia Research.  39:505-509. 2015
2015 Sorafenib in relapsed AML with FMS-like receptor tyrosine kinase-3 internal tandem duplication mutationJournal of the National Comprehensive Cancer Network : JNCCN.  13:508-514. 2015
2015 The spectrum of thrombin in acute coronary syndromes 2015
2015 Meta-analysis of 21- Versus 22-G aspiration needle during endobronchial ultrasound-Guided transbronchial needle aspirationJournal of Bronchology.  22:107-113. 2015
2015 Low birth weight at term and its determinants in a tertiary hospital of nepal:A case-control studyPLoS One.  10. 2015
2015 Second primary malignancies in Waldenstrom’s macroglobulinemia: a US population-based studyCancer Causes and Control.  26:645-647. 2015
2015 Comparison between saddle versus non-saddle pulmonary embolism: Insights from nationwide inpatient sampleInternational Journal of Cardiology.  180:58-59. 2015
2015 Gender Differences and Clustering of Modifiable Risk Factors of Non-communicable Diseases Among Medical Students: A Cross Sectional Study in NepalJournal of Community Health.  40:147-152. 2015
2015 Lack of "weekend effect" on mortality for pulmonary embolism admissions in 2011: Data from nationwide inpatient sampleInternational Journal of Cardiology.  180:151-153. 2015
2015 Mortality, length of stay, and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in the United StatesSupportive Care in Cancer.  23:615-617. 2015
2015 A case of Brugada Syndrome unmasked by a postoperative febrile stateCaspian Journal of Internal Medicine.  6:43-45. 2015
2015 Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: A retrospective analysis of the Surveillance, Epidemiology and End Results databaseTherapeutic Advances in Hematology.  6:308-312. 2015
2015 Demographic and other characteristics of nodal non-Hodgkin's lymphoma managed in academic versus non-academic centersTherapeutic Advances in Hematology.  6:223-227. 2015
2015 Grade and prognosis in localized primary angiosarcomaClinical Breast Cancer.  15:266-269. 2015
2015 Ibrutinib has some activity in Richter's syndromeBlood Cancer Journal.  5:e277. 2015
2015 Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: A matched cohort studyBlood.  125:3359-3360. 2015
2015 Incidence trend of esophageal squamous cell carcinoma: an analysis of Surveillance Epidemiology, and End Results (SEER) databaseCancer Causes and Control.  26:159-161. 2015
2015 Late onset seroma post-thymectomy presenting as cardiac tamponade.Journal of Community Hospital Internal Medicine Perspectives.  5:27459. 2015
2015 Meta-analysis on efficacy and safety of new oral anticoagulants for venous thromboembolism prophylaxis in elderly elective postarthroplasty patients 2015
2015 Obstructive sleep apnea syndrome and secondary polycythemia: Analysis of the nationwide inpatient sampleSleep Medicine.  16:205-206. 2015
2015 Seasonal and regional variation of thrombotic thrombocytopenic purpura in the United States: Insights from the Nationwide Inpatient SampleAmerican Journal of Hematology.  90:E24. 2015
2015 Seasonal variation of immune thrombocytopenic purpura related hospitalizations among adults in the USA: Analysis of the nationwide inpatient sample databaseTherapeutic Advances in Hematology.  6:217-218. 2015
2015 Shorter (≤ 6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: A meta-analysis of randomized clinical trialsCatheterization and Cardiovascular Interventions.  85:34-40. 2015
2015 The spectrum of genetic mutations in breast cancer 2015
2015 Treatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: Role of fludarabine?Therapeutic Advances in Hematology.  6:88-92. 2015
2014 Tuberous sclerosis complex with autosomal dominant polycystic kidney disease: A rare duoBMJ Case Reports.  2014. 2014
2014 Acute megakaryocytic leukemia is associated with worse outcomes than other types of acute myeloid leukemiaBlood.  124:3833-3834. 2014
2014 Aortic dissection as a rare complication of percutaneous coronary interventionBMJ Case Reports.  2014. 2014
2014 Left atrial appendage aneurysm: A systematic review of 82 cases 2014
2014 Seasonal variation in the presentation of thyroid cancer in the USA: an analysis of the Surveillance, Epidemiology and End Results RegistryCancer Causes and Control.  25:1583-1585. 2014
2014 Novel mutations in a patient with ALK-rearranged lung cancer: To the editorNew England Journal of Medicine.  371:1655-1656. 2014
2014 A case of toxic epidermal necrolysis caused by trimethoprim- sulfamethoxazoleBMJ Case Reports2014
2014 A case of left main coronary artery embolus further embolising to the left anterior descending arteryBMJ Case Reports2014
2014 Posterior reversible encephalopathy syndrome (PRES) in a patient with late postpartum eclampsiaBMJ Case Reports2014
2014 Preventive PCI versus culprit lesion stenting during primary PCI in acute STMI: A systematic review and meta-analysisOpen Heart.  1. 2014
2014 Disseminated toxocariasis in an immunocompetent hostAsian Pacific Journal of Tropical Biomedicine.  4:838-840. 2014
2014 Emerging therapy options in Heparin-Induced ThrombocytopeniaCardiovascular and Hematological Agents in Medicinal Chemistry.  12:50-58. 2014
2014 Multiple mycotic coronary artery aneurysms in a patient with aortic valve endocarditis 2014
2014 Right atrial appendage aneurysm: A systematic review 2014
2013 Acute biliary pancreatitis: An experience in a tertiary level hospital of NepalIndian Journal of Surgery.  75:449-453. 2013
2013 Haemophagocytic lymphohistiocytosis mimicking septic shock after the initiation of chemotherapy for squamous cell carcinoma of the neck.BMJ Case Reports.  2013. 2013
2013 Quality of life among people living with acquired immune deficiency syndrome receiving anti-retroviral therapy: A study from Nepal 2013
2013 Benzocaine-induced methaemoglobinaemia: A life-threatening complication after a transoesophageal echocardiogram (TEE)BMJ Case Reports2013
2013 Left ventricular non-compaction presenting with heart failure and intramural thrombusBMJ Case Reports2013
2013 Haemophagocytic lymphohistiocytosis mimicking septic shock after the initiation of chemotherapy for squamous cell sarcinoma of the neckBMJ Case Reports2013
2013 Risk factors for surgical site infections in abdominal surgery: A study in NepalSurgical Infections.  14:313-318. 2013
2012 Retroperitoneal necrotizing fasciitis presenting with peritonism in a 33-year-old Nepalese man: A case reportJournal of Medical Case Reports.  6. 2012
2012 Retroperitoneal necrotizing fasciitis presenting with peritonism in a 33-year-old Nepalese man: a case report.Journal of Medical Case Reports.  6:53. 2012
2012 Cardiovascular health risk behavior among medical students in a teaching hospital.Journal of Nepal Health Research Council.  10:187-191. 2012
2012 Morphoea Profunda presenting with atrophic skin lesions in a 26 year old female: A case reportClinical Medicine Insights: Case Reports.  5:57-62. 2012
2012 Successful treatment of methicillin-resistant Staphylococcus aureus bacteraemia and cholecystitisBMJ Case Reports2012
2011 High prevalence of depression and anxiety symptoms among hospitalized geriatric medical inpatients: A study from a tertiary level hospital in NepalUniversity of Toronto medical journal.  88:32-35. 2011
2011 A case of precocious puberty in a setting with limited resources 2011

Chapter

Year Title Altmetric
2016 Autologous and allogeneic hematopoietic stem cell transplantation for diffuse large B-cell lymphoma.  91-103. 2016
2015 Malignant pericardial effusion: Current diagnosis and treatment.  91-112. 2015

Investigator On

  • BMT Survivor Study-2 (BMTSS-2)  awarded by National Cancer Institute/NIH/DHHS
  • Private Grant  awarded by ABBVIE INC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by JUNO THERAPEUTICS
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by JUNO THERAPEUTICS
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by Genentech
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by IONIS PHARMACEUTICALS, INC.
  • Private Grant  awarded by JUNO THERAPEUTICS
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by Sanofi US Services Inc
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by JUNO THERAPEUTICS
  • Private Grant  awarded by FATE THERAPEUTICS, INC.
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by Genzyme Corporation
  • Private Grant  awarded by EUSA PHARMA
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by Janssen
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by Amgen Foundation, Inc.
  • Private Grant  awarded by BRISTOL-MYERS SQUIBB COMPANY
  • Private Grant  awarded by BEIGENE
  • UAB 1815: Phase 2 Trial of Intensive Chemo-immu,otherapy with Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Relapsed.Refractory Myeloma In the context of Salvage Autologous Hematopoietic Cell Transplantation  awarded by Memorial Sloan-Kettering Cancer Center
  • UAB 2232:A Multisite, Phase II Study of IsatuxiMab, Pomalidomide, Elotuzumab and DExamethasone in Relapsed and/or Refractory Multiple Myeloma  awarded by Medical College of Wisconsin
  • Education And Training

  • University of Tennessee Health Science Center, Internship
  • University of Tennessee Health Science Center, Residency
  • Yale University School of Medicine, Postdoctoral Fellowship
  • Master of Health Related in Health Services / Allied Health / Health Sciences, Yale University 2019
  • Bachelor of Medicine & Surgery (MBBS), Tribhuvan University 2012
  • Full Name

  • Smith Giri